Literature DB >> 17593135

Intestinal permeability and irritable bowel syndrome.

M Camilleri1, H Gorman.   

Abstract

Based on a systematic PubMed search, this short review addresses why intestinal permeability may be important in the pathobiology of irritable bowel syndrome (IBS), the evidence of abnormal permeability in patients with IBS, and the pros and cons of the different probe molecules available to assess intestinal permeability. While a subgroup of patients with IBS appears to have evidence of increased intestinal permeability, improvements in the methods and validation are key to further research in this field in order to better understand intestinal barrier functions in IBS.

Entities:  

Mesh:

Year:  2007        PMID: 17593135     DOI: 10.1111/j.1365-2982.2007.00925.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  56 in total

Review 1.  Regulation of intestinal epithelial permeability by tight junctions.

Authors:  Takuya Suzuki
Journal:  Cell Mol Life Sci       Date:  2012-07-11       Impact factor: 9.261

2.  Pro-inflammatory chemokine C-C motif ligand 16 (CCL-16) dysregulation in irritable bowel syndrome (IBS): a pilot study.

Authors:  A Y Del Valle-Pinero; A C Martino; T J Taylor; B L Majors; N S Patel; M M Heitkemper; W A Henderson
Journal:  Neurogastroenterol Motil       Date:  2011-09-23       Impact factor: 3.598

Review 3.  New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond.

Authors:  Emanuele Sinagra; Gaetano Cristian Morreale; Ghazaleh Mohammadian; Giorgio Fusco; Valentina Guarnotta; Giovanni Tomasello; Francesco Cappello; Francesca Rossi; Georgios Amvrosiadis; Dario Raimondo
Journal:  World J Gastroenterol       Date:  2017-09-28       Impact factor: 5.742

Review 4.  New insights into visceral hypersensitivity--clinical implications in IBS.

Authors:  QiQi Zhou; G Nicholas Verne
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-06       Impact factor: 46.802

Review 5.  An Overview and Proposed Research Framework for Studying Co-Occurring Mental- and Physical-Health Dysfunction.

Authors:  Sarah L Hagerty; Jarrod M Ellingson; Timothy B Helmuth; L Cinnamon Bidwell; Kent E Hutchison; Angela D Bryan
Journal:  Perspect Psychol Sci       Date:  2019-06-07

Review 6.  Intestinal barrier: A gentlemen's agreement between microbiota and immunity.

Authors:  Andrea Moro Caricilli; Angela Castoldi; Niels Olsen Saraiva Câmara
Journal:  World J Gastrointest Pathophysiol       Date:  2014-02-15

7.  Gastrointestinal permeability in patients with irritable bowel syndrome assessed using a four probe permeability solution.

Authors:  Arseima Y Del Valle-Pinero; Hendrick E Van Deventer; Nicolaas H Fourie; Angela C Martino; Nayan S Patel; Alan T Remaley; Wendy A Henderson
Journal:  Clin Chim Acta       Date:  2013-01-14       Impact factor: 3.786

8.  MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome.

Authors:  QiQi Zhou; Wiley W Souba; Carlo M Croce; G Nicholas Verne
Journal:  Gut       Date:  2009-12-01       Impact factor: 23.059

Review 9.  Possible links between intestinal permeability and food processing: A potential therapeutic niche for glutamine.

Authors:  Jean Robert Rapin; Nicolas Wiernsperger
Journal:  Clinics (Sao Paulo)       Date:  2010-06       Impact factor: 2.365

10.  Lubiprostone: evaluation of the newest medication for the treatment of adult women with constipation-predominant irritable bowel syndrome.

Authors:  Tisha N Lunsford; Lucinda A Harris
Journal:  Int J Womens Health       Date:  2010-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.